This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can Tenet Healthcare's $910M Divestment in Alabama Cure its Debt Woes?
by Zacks Equity Research
More such divestments can be expected from THC in the coming days, which will likely fuel the company's de-leveraging initiatives.
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
3 Hospital Stocks to Buy With Strong Earnings Estimate Revisions
by Nalak Das
The U.S. hospital industry has been flying high in the past year. Three hospital stocks to buy are: HCA, THC, UHS.
Ensign Group Stock Up 19.2% in Six Months: More Growth Ahead?
by Zacks Equity Research
ENSG drives growth with strong segmental performance, cash flows and robust acquisitions, positioning itself as a leader in skilled healthcare services.
Tenet Adds $8B in Market Cap in 2024: Why it's Still a Healthy Buy
by Kaibalya Pravo Dey
Despite being close to its peak, THC remains a compelling buy due to its solid fundamentals, appealing valuation, and upward trend in earnings estimates.
Humana and Interwell Health Expand Value-Based Support to Florida
by Zacks Equity Research
HUM and Interwell Health add Florida to their value-based kidney care program in a bid to improve health outcomes.
Universal Health Services, Inc. (UHS) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Universal Health Services (UHS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare
by Zacks Equity Research
NetApp, Cabot, Leidos, Charles River Associates and HCA Healthcare are part of the Zacks Screen of the Week article.
Centene's Health Net Wins Medi-Cal Contract in California
by Zacks Equity Research
CNC's Health Net unit secures a 54-month Medi-Cal dental contract, which, in turn, is likely to boost its Medicaid membership and presence across California.
5 Dividend Growth Stocks Likely to Outperform Amid Low Rates
by Sweta Killa
NetApp, Cabot, Leidos Holdings, Charles River and HCA Healthcare could be compelling picks amid a low rate scenario.
Stocks Make Record Highs: 3 Top Buys for the Next Bull Run
by Ethan Feller
HCA Healthcare, Fortinet and PayPal stocks all offer compelling bullish opportunities
HCA (HCA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
HCA (HCA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
How HCA Healthcare (HCA) Stock Stands Out in a Strong Industry
by Zacks Equity Research
HCA Healthcare (HCA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
HCA Healthcare (HCA) Boasts Earnings & Price Momentum: Should You Buy?
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
New Strong Buy Stocks for September 20th
by Zacks Equity Research
QFIN, CLCO, HCA, STRL and CSGS have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2024.
Universal Health Up 23% in 3 Months: Time to Buy or Miss the Boat?
by Debasmita Chatterjee
UHS witnesses revenue growth from increased patient volumes and strategic initiatives. An extensive treatment network remains an added strength.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Zacks.com featured highlights include HCA Healthcare, Hubbell, Ferrari and Vertex
by Zacks Equity Research
HCA Healthcare, Hubbell, Ferrari and Vertex have been highlighted in this Screen of The Week article.
HCA Healthcare Stock Up 18.4% in 3 Months: Can You Afford to Miss Out?
by Zubia Masood
HCA benefits from expanding insurance coverage, rising demand and improving margins.
4 GARP Stocks to Scoop up for Maximum Returns
by Zacks Equity Research
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. HCA, HUBB, RACE and VERX are some stocks that hold promise.
HCA Healthcare (HCA) is a Top-Ranked Momentum Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New Strong Buy Stocks for September 12th
by Zacks Equity Research
AFRM, SBSI, LYTS, CM and HCA have been added to the Zacks Rank #1 (Strong Buy) List on September 12, 2024.
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
by Zacks Equity Research
CI benefits from improved premiums resulting from an extensive customer base. Buyouts and adequate operating cash flows are other tailwinds.